drugset / Trial / NCT05344274

Retinal Blood Flow and Autoregulation

NCT05344274 ↗

Phase 4 Recruiting 90 enrolled University of Maryland, Baltimore
NaSingle-groupOpen-labelDiagnostic

Summary

The purpose of this study is to establish autoregulation of retinal blood flow in arterioles and capillaries as a biomarker for early primary open angle glaucoma.

Timeline

Start
2022-05-23
Primary completion
2027-09
Completion
2027-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Isocapnic Oxygen Unknown — —

Indications